Authors: Boyko, AN Khachanova, NV Buglak, AV Demina, TL Belyaeva, IA Lash, NV Serkov, SV Gusev, EI

Citation: An. Boyko et al., Possibility of the use of several clinical, genetic and MRI characteristics for prognosis of effects of betaferon-1b treatment in multiple sclerosis, IAN FIZ, 64(11), 2000, pp. 53-59

Authors: Gusev, EI Belyaeva, IA Chekhonin, VP Demina, TL Boyko, AN Buglak, AV Gurina, OI

Citation: Ei. Gusev et al., Comparative clinical immunologic analysis of the remittent and secondary-progressive course of multiple sclerosis, ZH NEVR PS, 100(6), 2000, pp. 51-57

Authors: Boyko, AN Khachanova, NV Buglak, AV Demina, TL Belyaeva, IA Lash, NV Serkov, SV Gusev, EI

Citation: An. Boyko et al., Possibility of the use of several clinical, genetic and MRI characteristics for prognosis of effects of betaferon-1b treatment in multiple sclerosis, ZH NEVR PS, 100(12), 2000, pp. 53-59

Authors: Belyaeva, IA Gusev, EI Chekhonin, VP Demina, TL Boiko, AN Buglak, AV

Citation: Ia. Belyaeva et al., Blood-brain barrier, ZH NEVR PS, 99(8), 1999, pp. 57-62